Washington Examiner
Sign in Subscribe
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Tags › Posts tagged Pfizer

Tag: Pfizer

In this May 4, 2014 photo, the Pfizer logo is displayed on the exterior of a former Pfizer factory  in the Brooklyn borough of New York. Pfizer says it does not intend to make a takeover offer for British drugmaker AstraZeneca. The Monday, May 26, 2014 announcement comes a week after AstraZeneca's board rejected a proposed $119 billion buyout offer from Pfizer, the world's second-biggest drugmaker by revenue. (AP Photo/Mark Lennihan, File) Business

Pfizer pulls plug on push to buy AstraZeneca

Alex Veiga · May 26, 2014 6:29 pm
FILE - This Friday May 2, 2014 file photo shows an exterior view of the Two Kingdom Street building which houses the headquarters of AstraZeneca, in the Paddington area of London. The board of AstraZeneca has rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, Monday May 19, 2014, a decision that has caused a sharp slide in the U.K. company's share price as investors think it effectively brings an end to the protracted and increasingly bitter takeover saga. (AP Photo/Matt Dunham, File) Business

AstraZeneca rejects $119 billion offer from Pfizer

Washington Examiner · May 19, 2014 4:14 pm
Business

Pfizer raises offer, highlighting flurry of deals

The Associated Press · May 19, 2014 8:25 am
Business

Board of British drugmaker AstraZeneca rejects new $119 billion takeover offer from Pfizer

Washington Examiner · May 19, 2014 6:46 am
Business

Pfizer ups offer for AstraZeneca again, to $119B

Linda Johnson · May 19, 2014 4:06 am
Business

Pfizer chief says jobs will go in takeover

Danica Kirka · May 13, 2014 3:44 pm
An exterior view of the Two Kingdom Street building which houses the headquarters of AstraZeneca, in the Paddington area of London, Friday, May 2, 2014.  The board of pharmaceutical company AstraZeneca on Friday rejected drug maker Pfizer's sweetened takeover offer. Pfizer earlier in the day said it is offering 50 pounds ($84) a share in cash and stock, a 7.3 increase on a previous bid. The offer values AstraZeneca at $106 billion. (AP Photo/Matt Dunham) Business

AstraZeneca rejects sweetened Pfizer takeover bid

DANICA KIRKALINDA A. JOHNSON · May 2, 2014 9:34 pm
Business

AstraZeneca board rejects sweetened takeover offer from Pfizer

Washington Examiner · May 2, 2014 9:56 am
Business

Pfizer still pursuing AstraZeneca after 2nd rebuff

DANICA KIRKALINDA A. JOHNSON · April 28, 2014 6:59 pm
Business

AstraZeneca shares soar on Pfizer interest

Danica Kirka · April 28, 2014 11:16 am
Pfizer Inc. proposed buying AstraZeneca Plc for about 58.8 billion pounds ($98.7 billion) in what would rank as the biggest-ever takeover of a U.K. company and continues to be interested in a deal after being spurned. (AP image) Healthcare

Pfizer still wants AstraZeneca after $98.7 billion bid rejected

oliver-staley, phil-serafino · April 28, 2014 4:00 am
Business

Pfizer to help investors with dividend, buybacks

The Associated Press · April 24, 2014 9:08 pm
Advertisement
  • ‹Previous page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • ›Next page
Page 29 of 30
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement